AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 133 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,298 | -22.4% | 28,230 | -3.0% | 0.00% | 0.0% |
Q2 2023 | $1,672 | -40.0% | 29,099 | -60.8% | 0.00% | -50.0% |
Q1 2023 | $2,785 | -40.1% | 74,274 | -55.3% | 0.00% | -42.9% |
Q4 2022 | $4,652 | -99.9% | 166,040 | -17.4% | 0.01% | -12.5% |
Q3 2022 | $5,650,000 | -46.7% | 201,065 | -34.0% | 0.01% | -46.7% |
Q2 2022 | $10,600,000 | -24.6% | 304,672 | -22.2% | 0.02% | -16.7% |
Q1 2022 | $14,058,000 | +45.1% | 391,585 | -5.9% | 0.02% | +50.0% |
Q4 2021 | $9,690,000 | +156.8% | 416,049 | +109.6% | 0.01% | +140.0% |
Q3 2021 | $3,773,000 | +28.2% | 198,472 | +36.0% | 0.01% | +25.0% |
Q2 2021 | $2,942,000 | +187.3% | 145,918 | +161.2% | 0.00% | +300.0% |
Q1 2021 | $1,024,000 | -89.8% | 55,869 | -89.3% | 0.00% | -95.7% |
Q4 2019 | $10,050,000 | +11.7% | 520,984 | +14.8% | 0.02% | +9.5% |
Q3 2019 | $9,000,000 | +156.3% | 453,835 | +172.9% | 0.02% | +162.5% |
Q2 2019 | $3,511,000 | +14.1% | 166,302 | +10.5% | 0.01% | +14.3% |
Q1 2019 | $3,076,000 | +478.2% | 150,541 | +332.1% | 0.01% | +600.0% |
Q2 2018 | $532,000 | – | 34,840 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EAM Investors, LLC | 173,018 | $3,187,000 | 0.42% |
GLOBEFLEX CAPITAL L P | 50,686 | $934,000 | 0.23% |
KALMAR INVESTMENTS INC /DE/ | 240,648 | $4,433,000 | 0.23% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 63,661 | $1,173,000 | 0.19% |
OBERWEIS ASSET MANAGEMENT INC/ | 27,200 | $501,000 | 0.15% |
Invictus RG | 11,950 | $220,000 | 0.15% |
ACADIAN ASSET MANAGEMENT LLC | 1,502,151 | $27,668,000 | 0.13% |
FOX RUN MANAGEMENT, L.L.C. | 12,600 | $232,000 | 0.12% |
Piermont Capital Management Inc. | 26,153 | $482,000 | 0.11% |
FEDERATED HERMES, INC. | 1,344,684 | $24,769,000 | 0.07% |